A 70-year-old man comes to the clinic for routine follow-up of hypertension and is found to have new atrial fibrillation of unknown duration. Atrial fibrillation increases the risk of mortality and ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

A St. Louis, Missouri medical device company is raising money in preparation for clinical trials of its pain-free cardioversion therapy for atrial fibrillation, developed by a former Case Western ...

Recent-onset atrial fibrillation, defined as an onset within one week, is a major issue in clinical practice, and recent advances have shown that cardioversion to normal sinus rhythm provides better ...

Introduction: There is insufficient evidence on the efficacy and safety of pharmacological cardioversion of recent‑onset atrial fibrillation (AF) in elderly patients. Antazoline has been shown to be ...

Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...

BARCELONA, SPAIN — A randomized trial tentatively pointing to fewer strokes vs standard therapy when a new oral anticoagulant (NOAC) is used before cardioversion for atrial fibrillation (AF) may edge ...

LISBON — After delaying cardioversion based on a "wait-and-see" (WAS) approach for recent onset, symptomatic atrial fibrillation (AF) was just as good as acute cardioversion (AC) in getting patients ...

However, several factors confound the role of inflammation in generation and perpetuation of AF. As an example, failure to show a correlation between baseline hsCRP levels and maintenance of sinus ...

Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set statistic alerts) please log in with your personal ...

Newswise — A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients ...